Literature DB >> 35574856

ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress.

Xiaoding Wang1, Guangyu Zhang2, Subhajit Dasgupta2, Erica L Niewold2, Chao Li2, Qinfeng Li2, Xiang Luo2, Lin Tan3, Anwarul Ferdous2, Philip L Lorenzi3, Beverly A Rothermel2,4, Thomas G Gillette2, Christopher M Adams5, Philipp E Scherer6, Joseph A Hill2,4, Zhao V Wang2.   

Abstract

BACKGROUND: Cellular redox control is maintained by generation of reactive oxygen/nitrogen species balanced by activation of antioxidative pathways. Disruption of redox balance leads to oxidative stress, a central causative event in numerous diseases including heart failure. Redox control in the heart exposed to hemodynamic stress, however, remains to be fully elucidated.
METHODS: Pressure overload was triggered by transverse aortic constriction in mice. Transcriptomic and metabolomic regulations were evaluated by RNA-sequencing and metabolomics, respectively. Stable isotope tracer labeling experiments were conducted to determine metabolic flux in vitro. Neonatal rat ventricular myocytes and H9c2 cells were used to examine molecular mechanisms.
RESULTS: We show that production of cardiomyocyte NADPH, a key factor in redox regulation, is decreased in pressure overload-induced heart failure. As a consequence, the level of reduced glutathione is downregulated, a change associated with fibrosis and cardiomyopathy. We report that the pentose phosphate pathway and mitochondrial serine/glycine/folate metabolic signaling, 2 NADPH-generating pathways in the cytosol and mitochondria, respectively, are induced by transverse aortic constriction. We identify ATF4 (activating transcription factor 4) as an upstream transcription factor controlling the expression of multiple enzymes in these 2 pathways. Consistently, joint pathway analysis of transcriptomic and metabolomic data reveal that ATF4 preferably controls oxidative stress and redox-related pathways. Overexpression of ATF4 in neonatal rat ventricular myocytes increases NADPH-producing enzymes' whereas silencing of ATF4 decreases their expression. Further, stable isotope tracer experiments reveal that ATF4 overexpression augments metabolic flux within these 2 pathways. In vivo, cardiomyocyte-specific deletion of ATF4 exacerbates cardiomyopathy in the setting of transverse aortic constriction and accelerates heart failure development, attributable, at least in part, to an inability to increase the expression of NADPH-generating enzymes.
CONCLUSIONS: Our findings reveal that ATF4 plays a critical role in the heart under conditions of hemodynamic stress by governing both cytosolic and mitochondrial production of NADPH.

Entities:  

Keywords:  cell death; fibrosis; glycine; heart failure; metabolomics

Mesh:

Substances:

Year:  2022        PMID: 35574856      PMCID: PMC9351829          DOI: 10.1161/CIRCRESAHA.122.321050

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   23.213


  50 in total

Review 1.  Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.

Authors:  Paul D Ray; Bo-Wen Huang; Yoshiaki Tsuji
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

2.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

Review 3.  NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences.

Authors:  Weihai Ying
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 4.  The pentose phosphate pathway and cancer.

Authors:  Krushna C Patra; Nissim Hay
Journal:  Trends Biochem Sci       Date:  2014-07-15       Impact factor: 13.807

5.  Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.

Authors:  Abdulrahman K Doughan; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2007-12-20       Impact factor: 17.367

6.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.

Authors:  H A Rockman; R S Ross; A N Harris; K U Knowlton; M E Steinhelper; L J Field; J Ross; K R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

7.  Mitochondrial NADP+ is essential for proline biosynthesis during cell growth.

Authors:  Diem H Tran; Rushendhiran Kesavan; Halie Rion; Mona Hoseini Soflaee; Ashley Solmonson; Divya Bezwada; Hieu S Vu; Feng Cai; John A Phillips; Ralph J DeBerardinis; Gerta Hoxhaj
Journal:  Nat Metab       Date:  2021-04-08

8.  Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy.

Authors:  Davy Vanhoutte; Tobias G Schips; Alexander Vo; Kelly M Grimes; Tanya A Baldwin; Matthew J Brody; Federica Accornero; Michelle A Sargent; Jeffery D Molkentin
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

9.  AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Authors:  Roselle Gélinas; Florence Mailleux; Justine Dontaine; Laurent Bultot; Bénédicte Demeulder; Audrey Ginion; Evangelos P Daskalopoulos; Hrag Esfahani; Emilie Dubois-Deruy; Benjamin Lauzier; Chantal Gauthier; Aaron K Olson; Bertrand Bouchard; Christine Des Rosiers; Benoit Viollet; Kei Sakamoto; Jean-Luc Balligand; Jean-Louis Vanoverschelde; Christophe Beauloye; Sandrine Horman; Luc Bertrand
Journal:  Nat Commun       Date:  2018-01-25       Impact factor: 14.919

10.  Mitochondrial pyruvate carriers are required for myocardial stress adaptation.

Authors:  Yuan Zhang; Paul V Taufalele; Jesse D Cochran; Isabelle Robillard-Frayne; Jonas Maximilian Marx; Jamie Soto; Adam J Rauckhorst; Fariba Tayyari; Alvin D Pewa; Lawrence R Gray; Lynn M Teesch; Patrycja Puchalska; Trevor R Funari; Rose McGlauflin; Kathy Zimmerman; William J Kutschke; Thomas Cassier; Shannon Hitchcock; Kevin Lin; Kevin M Kato; Jennifer L Stueve; Lauren Haff; Robert M Weiss; James E Cox; Jared Rutter; Eric B Taylor; Peter A Crawford; E Douglas Lewandowski; Christine Des Rosiers; E Dale Abel
Journal:  Nat Metab       Date:  2020-10-26
View more
  1 in total

Review 1.  NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease.

Authors:  William M Curtis; William A Seeds; Mark P Mattson; Patrick C Bradshaw
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.